Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days after Acceptance | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in November 2026 (Volume 28, Issue 2) Submit Paper

RISK FACTORS AND HISTOLOGICAL TYPES OF ENDOMETRIAL CARCINOMA AT SHENDI UNIVERSITY TUMOR THERAPY CENTER, SUDAN

Breadcrumb

  • Home
  • RISK FACTORS AND HISTOLOGICAL TYPES OF ENDOMETRIAL CARCINOMA AT SHENDI UNIVERSITY TUMOR THERAPY CENTER, SUDAN

Sami Hummeda Elnour Hummeda 1, *, Elaf Elfakei 2 and Ibrahim Bakhit Yousif Elemam 3

1 Department of Obstetrics and Gynecology Faculty of Medicine, Shendi University, Shendi, Sudan.
2 Department of Obstetrics and Gynaecology, Al Mak Nimir Hospital, in Shendi locality, Sudan. 
3 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, Shendi University, Shendi, Sudan.
* Corresponding Author
ORCID Details
Sami Hummeda Elnour Hummeda: https://orcid.org/ 0009-0005-7097-3734 
Elaf Elfakei: https://orcid.org/0009-0002-2999-5593
Ibrahim Bakhit Yousif Elemam: https://orcid.org/ 0009-0006-3591-0049

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2026, 28(01), 156–162

Article DOI: 10.30574/wjbphs.2026.28.1.0516

DOI url: https://doi.org/10.30574/wjbphs.2026.28.1.0516

Received on 15 September 2026; revised on 22 October 2026; accepted on 24 October 2026

Background: Uterine endometrial cancer is the most prevalent gynaecologic malignancy, representing a significant cause of morbidity and mortality, worldwide. Understanding the risk factors, diagnosis, and management of endometrial cancer necessitates a comprehensive approach from an interprofessional team. This study aimed to evaluate the risk factors and histological types of endometrial carcinoma among patients at the Tumor Therapy and Cancer Research Center at Shendi University. The study was conducted between September 2022 and March 2023. 
Methods: A descriptive cross-sectional hospital-based study was conducted involving 80 participants diagnosed with endometrial carcinoma. 
Results: Out of the 80 patients, 2 (2.5%) were using estrogen, 21 (26.2%) had hypertension, and 13 (16.3%) had diabetes mellitus (DM). Other risk factors included polycystic ovary syndrome (2.5%) and a history of prior pelvic radiation (1.3%). Family histories of cancers were notable, with 14 (17.5%) having a family history of breast cancer, 14 (11.2%) for endometrial cancer, and 8 (10.0%) for colorectal cancer. Disease staging revealed IA and IB stages in 26 patients each (32.5%). The predominant histopathological subtype was endometrioid adenocarcinoma, accounting for 67 (83.7%) cases. 
Conclusion: In summary, early marriage was significantly associated with a higher prevalence of endometrial adenocarcinoma, emphasizing the potential need for targeted education and screening for women who marry at a younger age. while advanced age was associated with advanced tumor grade, and the associations were statistically significant.

Endometroid Adenocarcinoma, Uterine Cancer, Endometrial Cancer, Sudan

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0516.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Sami Hummeda Elnour Hummeda, Elaf Elfakei and Ibrahim Bakhit Yousif Elemam. RISK FACTORS AND HISTOLOGICAL TYPES OF ENDOMETRIAL CARCINOMA AT SHENDI UNIVERSITY TUMOR THERAPY CENTER, SUDAN. World Journal of Biology Pharmacy and Health Sciences, 2026, 28(01), 156–162. Article DOI: https://doi.org/10.30574/wjbphs.2026.28.1.0516

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution